Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $254.37 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $87.27 | 5 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $39.60 | 2 | $0 (2023) |
| Neuronetics, Inc. | $35.78 | 2 | $0 (2022) |
| AbbVie Inc. | $28.08 | 1 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $25.20 | 1 | $0 (2018) |
| ITI, Inc. | $19.66 | 1 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $18.78 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $54.13 | 2 | AbbVie Inc. ($28.08) |
| 2022 | $93.22 | 5 | Neuronetics, Inc. ($35.78) |
| 2019 | $32.43 | 2 | Alkermes, Inc. ($32.43) |
| 2018 | $74.59 | 4 | Alkermes, Inc. ($35.84) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/21/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: PSYCHIATRY | ||||||
| 04/05/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Neuropsychiatry | ||||||
| 06/28/2022 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $17.89 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 06/28/2022 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $17.89 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 05/12/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: PSYCHIATRY | ||||||
| 04/15/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: CNS | ||||||
| 09/19/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: CNS | ||||||
| 06/20/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: CNS | ||||||
| 09/20/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: PSYCHIATRY | ||||||
| 05/17/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: CNS | ||||||
| 04/05/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: CNS | ||||||
| 01/18/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 77 | 170 | $22,956 | $9,120 |
| 2022 | 2 | 46 | 119 | $15,841 | $7,274 |
| 2021 | 3 | 49 | 74 | $10,720 | $6,155 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 76 | $12,504 | $5,424 | 43.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 82 | $9,950 | $3,398 | 34.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 12 | $501.72 | $297.90 | 59.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 77 | $9,163 | $3,717 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 42 | $6,678 | $3,557 | 53.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 28 | $4,452 | $2,512 | 56.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 35 | $4,165 | $2,121 | 50.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 11 | 11 | $2,103 | $1,522 | 72.4% |
About Dr. Jairam Das, MD
Dr. Jairam Das, MD is a Psychiatry healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2008. The National Provider Identifier (NPI) number assigned to this provider is 1164686176.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jairam Das, MD has received a total of $254.37 in payments from pharmaceutical and medical device companies, with $54.13 received in 2023. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($254.37).
As a Medicare-enrolled provider, Das has provided services to 172 Medicare beneficiaries, totaling 363 services with total Medicare billing of $22,549. Data is available for 3 years (2021–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Springfield, MO
- Active Since 07/18/2008
- Last Updated 11/07/2019
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1164686176
Products in Payments
- ARISTADA (Drug) $51.43
- Aristada 441 mg (Drug) $35.84
- NEUROSTAR TMS THERAPY SYSTEM (Device) $35.78
- VRAYLAR (Drug) $28.08
- ABILIFY ASIMTUFII (Drug) $26.05
- LATUDA (Drug) $25.20
- CAPLYTA (Drug) $19.66
- INGREZZA (Drug) $18.78
- ABILIFY MAINTENA (Drug) $13.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Springfield
Dr. Kalpana Vishnupad, M.d, M.D
Psychiatry — Payments: $63,945
Dr. Andrea Stonecipher, M.d, M.D
Psychiatry — Payments: $28,609
Dr. Shirlann Knight, M.d, M.D
Psychiatry — Payments: $9,255
Dr. Umamaheswara Vellanki, M.d, M.D
Psychiatry — Payments: $9,082
Dr. Dennis Dobard, M.d, M.D
Psychiatry — Payments: $8,804
Dr. Obiora Onwuameze, Md, Ms, Phd, MD, MS, PHD
Psychiatry — Payments: $6,358